Cargando…
Engaging community pharmacists in the primary prevention of cardiovascular disease: protocol for the Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) pilot study
BACKGROUND: Cardiovascular disease (CVD) is the leading cause of death globally. Community pharmacist intervention studies have demonstrated clinical effectiveness for improving several leading individual CVD risk factors. Primary prevention strategies increasingly emphasise the need for considerati...
Autores principales: | Mc Namara, Kevin P, George, Johnson, O'Reilly, Sharleen L, Jackson, Shane L, Peterson, Gregory M, Howarth, Helen, Bailey, Michael J, Duncan, Gregory, Trinder, Peta, Morabito, Elizabeth, Finch, Jill, Bunker, Stephen, Janus, Edward, Emery, Jon, Dunbar, James A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941496/ https://www.ncbi.nlm.nih.gov/pubmed/20819236 http://dx.doi.org/10.1186/1472-6963-10-264 |
Ejemplares similares
-
Effectiveness of pharmacist’s intervention in the management of cardiovascular diseases
por: Omboni, Stefano, et al.
Publicado: (2018) -
Cardiovascular disease as a leading cause of death: how are pharmacists getting involved?
por: Mc Namara, Kevin, et al.
Publicado: (2019) -
The “affected” pharmacist and the “business as usual” pharmacist: Exploring the experiences of pharmacists during COVID-19 through cluster analysis
por: Johnston, Karlee, et al.
Publicado: (2023) -
PHARMACIST-LED INTERVENTIONS MAY HELP PREVENT CARDIOVASCULAR DISEASE
Publicado: (2019) -
The burden of COVID-19 on pharmacists
por: Johnston, Karlee, et al.
Publicado: (2021)